Scinopharm Taiwan (TPE:1789) 3-Year EBITDA Growth Rate : 9.60% (As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Scinopharm Taiwan 3-Year EBITDA Growth Rate?

Scinopharm Taiwan's EBITDA per Share for the three months ended in Dec. 2024 was NT$0.30.

During the past 12 months, Scinopharm Taiwan's average EBITDA Per Share Growth Rate was 10.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 9.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Scinopharm Taiwan was 9.60% per year. The lowest was -17.30% per year. And the median was -8.00% per year.

Competitive Comparison of Scinopharm Taiwan's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Scinopharm Taiwan's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scinopharm Taiwan's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Scinopharm Taiwan's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Scinopharm Taiwan's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Scinopharm Taiwan 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Scinopharm Taiwan (TPE:1789) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Scinopharm Taiwan 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Scinopharm Taiwan's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinopharm Taiwan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Nan-Ke 8th Road, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144

Website

https://www.scinopharm.com

Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is primarily engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. Schinopharm also conducts consulting and technical services. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The Company's sales revenue mainly arises from the manufacture and sales of Active Pharmaceutical Ingredient and injection products.

Scinopharm Taiwan Headlines

No Headlines